
Disc Medicine faces class action over alleged misleading FDA drug approval info causing 22% stock drop.
Rosen Law Firm is investigating a class action lawsuit against Disc Medicine, Inc. after the FDA issued a Complete Response Letter rejecting the company's new drug application for bitopertin due to uncertainties requiring more evidence. This announce...

